Analysis of the national surgical quality improvement program database in 19,100 patients undergoing implant-based breast reconstruction: complication rates with acellular dermal matrix

Plastic and Reconstructive Surgery

Volumn 132, Issue 5, 2013, Pages 1057-1066

  Ibrahim, Ahmed M S ^a   Shuster, Marina ^a   Koolen, Pieter G L ^a   Kim, Kuylhee ^a   Taghinia, Amir H ^a   Sinno, Hani H ^a   Lee, Bernard T ^a   Lin, Samuel J ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOMATERIAL;

ACELLULAR DERMAL MATRIX; ADULT; ARTICLE; BREAST AUGMENTATION; BREAST IMPLANT; BREAST TUMOR; FACTUAL DATABASE; FEMALE; HUMAN; MALE; MIDDLE AGED; RETROSPECTIVE STUDY; TISSUE EXPANSION; TOTAL QUALITY MANAGEMENT; BREAST NEOPLASMS;

ACELLULAR DERMIS; ADULT; BIOCOMPATIBLE MATERIALS; BREAST IMPLANTATION; BREAST IMPLANTS; BREAST NEOPLASMS; DATABASES, FACTUAL; FEMALE; HUMANS; MALE; MIDDLE AGED; QUALITY IMPROVEMENT; RETROSPECTIVE STUDIES; TISSUE EXPANSION;

EID: 84887293099     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/PRS.0b013e3182a3beec     Document Type: Article

References (51)

1. Centers for Disease Control and Prevention. Cancer preventions and control. Cancer among women. Available at: http://www.cdc.gov/cancer/dcpc/data/ women.htm. Accessed December 7, 2012.
2. Siegel R, Ward E, Brawley O, Jemal A. Cancer statistics, 2011: The impact of eliminating socioeconomic and racial disparities on premature cancer deaths. CA Cancer J Clin. 2011;61:212-236.
3. American Society of Plastic Surgeons. 2011 plastic surgery statistics report: 2011 reconstructive breast procedures. Available at: http://www.plasticsurgery.org/news-andresources/2011-statistics-.html. Accessed December 7, 2012.
4. Maxwell GP, Gabriel A. Use of the acellular dermal matrix in revisionary aesthetic breast surgery. Aesthet Surg J. 2009;29:485-493.
5. Davila AA, Seth AK, Wang E, et al. Human acellular dermis versus submuscular tissue expander breast reconstruction: A multivariate analysis of short-term complications. Arch Plast Surg. 2013;40:19-27.
6. Butler CE, Langstein HN, Kronowitz SJ. Pelvic, abdominal, and chest wall reconstruction with AlloDerm in patients at increased risk for mesh-related complications. Plast Reconstr Surg. 2005;116:1263-1275; discussion 1276.
7. Wainwright DJ. Use of an acellular allograft dermal matrix (AlloDerm) in the management of full-thickness burns. Burns 1995;21:243-248.
8. Chaplin JM, Costantino PD, Wolpoe ME, Bederson JB, Griffey ES, Zhang WX. Use of an acellular dermal allograft for dural replacement: An experimental study. Neurosurgery 1999;45:320-327.
9. Preminger BA, McCarthy CM, Hu QY, Mehrara BJ, Disa JJ. The influence of AlloDerm on expander dynamics and complications in the setting of immediate tissue expander/implant reconstruction: A matched-cohort study. Ann Plast Surg. 2008;60:510-513.
10. Namnoum JD. Expander/implant reconstruction with AlloDerm: Recent experience. Plast Reconstr Surg. 2009;124:387-394.
11. Breuing KH, Colwell AS. Inferolateral AlloDerm hammock for implant coverage in breast reconstruction. Ann Plast Surg. 2007;59:250-255.
12. Liu AS, Kao HK, Reish RG, Hergrueter CA, May JW Jr, Guo L. Postoperative complications in prosthesis-based breast reconstruction using acellular dermal matrix. Plast Reconstr Surg. 2011;127:1755-1762.
13. Komorowska-Timek E, Oberg KC, Timek TA, Gridley DS, Miles DA. The effect of AlloDerm envelopes on periprosthetic capsule formation with and without radiation. Plast Reconstr Surg. 2009;123:807-816.
14. Bindingnavele V, Gaon M, Ota KS, Kulber DA, Lee DJ. Use of acellular cadaveric dermis and tissue expansion in postmastectomy breast reconstruction. J Plast Reconstr Aesthet Surg. 2007;60:1214-1218.
15. Nguyen MD, Chen C, Colakoǧlu S, Morris DJ, Tobias AM, Lee BT. Infectious complications leading to explantation in implant-based breast reconstruction with AlloDerm. Eplasty 2010;10:e48.
16. Chun YS, Verma K, Rosen H, et al. Implant-based breast reconstruction using acellular dermal matrix and the risk of postoperative complications. Plast Reconstr Surg. 2010;125:429-436.
17. Birkmeyer JD, Shahian DM, Dimick JB, et al. Blueprint for a new American College of Surgeons: National Surgical Quality Improvement Program. J Am Coll Surg. 2008;207:777-782.
18. American College of Surgeons. ACS NSQIP. NSQIP history. Available at: http://site.acsnsqip.org/program-specifics/nsqip-history/. Accessed March 13, 2013.
19. American College of Surgeons. ACS NSQIP. Data collection, analysis and reporting. Available at: http://site.acsnsqip. org/program-specifics/data- collection-analysis-and-reporting/. Accessed March 13, 2013.
20. American College of Surgeons. ACS NSQIP. User guide for the 2011 participant use data file. Available at: http://site. acsnsqip.org/wp-content/ uploads/2012/03/2011-User-Guide-Final.pdf. Accessed April 19, 2013.
21. Slavin SA, Lin SJ. The use of acellular dermal matrices in revisional breast reconstruction. Plast Reconstr Surg. 2012;130(Suppl 2):70S-85S.
22. Le GM, O'Malley CD, Glaser SL, et al. Breast implants following mastectomy in women with early-stage breast cancer: Prevalence and impact on survival. Breast Cancer Res. 2005;7:R184-R193.
23. de Blacam C, Ogunleye AA, Momoh AO, et al. High body mass index and smoking predict morbidity in breast cancer surgery: A multivariate analysis of 26,988 patients from the national surgical quality improvement program database. Ann Surg. 2012;255:551-555.
24. Adetayo OA, Salcedo SE, Bahjri K, Gupta SC. The use of acellular dermal matrix in breast and abdominal wall surgery: A meta-analysis of outcomes and risk factors predictive of complications. Plast Reconstr Surg. 2011;127(Suppl 5):9.
25. Lanier ST, Wang ED, Chen JJ, et al. The effect of acellular dermal matrix use on complication rates in tissue expander/implant breast reconstruction. Ann Plast Surg. 2010;64:674-678.
26. Nahabedian MY. AlloDerm performance in the setting of prosthetic breast surgery, infection, and irradiation. Plast Reconstr Surg. 2009;124:1743-1753.
27. Mullen JT, Davenport DL, Hutter MM, et al. Impact of body mass index on perioperative outcomes in patients undergoing major intra-abdominal cancer surgery. Ann Surg Oncol. 2008;15:2164-2172.
28. Giles KA, Wyers MC, Pomposelli FB, et al. The impact of body mass index on perioperative outcomes of open and endovascular abdominal aortic aneurysm repair from the National Surgical Quality Improvement Program, 2005-2007. J Vasc Surg. 2010;52:1471-1477.
29. Witt A, Yavuz D, Walchetseder C, Strohmer H, Kubista E. Preoperative core needle biopsy as an independent risk factor for wound infection after breast surgery. Obstet Gynecol. 2003;101:745-750.
30. Bertin ML, Crowe J, Gordon SM. Determinants of surgical site infection after breast surgery. Am J Infect Control 1998;26:61-65.
31. Nieto A, Lozano M, Moro MT, Keller J, Carralafuente C. Determinants of wound infections after surgery for breast cancer. Zentralbl Gynakol. 2002;124:429-433.
32. Vinton AL, Traverso LW, Jolly PC. Wound complications after modified radical mastectomy compared with tylectomy with axillary lymph node dissection. Am J Surg. 1991;161:584-588.
33. Al-Refaie WB, Parsons HM, Henderson WG, et al. Body mass index and major cancer surgery outcomes: Lack of association or need for alternative measurements of obesity? Ann Surg Oncol. 2010;17:2264-2273.
34. Ismael H, Horst M, Farooq M, Jordon J, Patton JH, Rubinfeld IS. Adverse effects of preoperative steroid use on surgical outcomes. Am J Surg. 2011;201:305-308; discussion 308.
35. Vaid S, Bell T, Grim R, Ahuja V. Predicting risk of death in general surgery patients on the basis of preoperative variables using American College of Surgeons National Surgical Quality Improvement Program data. Perm J. 2012;16:10-17.
36. Kelly KJ, Greenblatt DY, Wan Y, et al. Risk stratification for distal pancreatectomy utilizing ACS-NSQIP: Preoperative factors predict morbidity and mortality. J Gastrointest Surg. 2011;15:250-259, discussion 259.
37. Gedaly R, McHugh PP, Johnston TD, Jeon H, Ranjan D, Davenport DL. Obesity, diabetes, and smoking are important determinants of resource utilization in liver resection: A multicenter analysis of 1029 patients. Ann Surg. 2009;249:414-419.
38. Singh N, Sidawy AN, DeZee KJ, Neville RF, Akbari C, Henderson W. Factors associated with early failure of infrainguinal lower extremity arterial bypass. J Vasc Surg. 2008;47:556-561.
39. Jordan SW, Mioton LM, Smetona J, et al. Resident involvement affects plastic surgery outcomes: An analysis of 10,356 patients from the NSQIP database. Plast Reconstr Surg, 2013;131:763-773.
40. Bhayani NH, Hyder O, Frederick W, et al. Effect of metabolic syndrome on perioperative outcomes after liver surgery: A National Surgical Quality Improvement Program (NSQIP) analysis. Surgery 2012;152:218-226.
41. Olsen MA, Lefta M, Dietz JR, et al. Risk factors for surgical site infection after major breast operation. J Am Coll Surg. 2008;207:326-335.
42. Neumayer L, Schifftner TL, Henderson WG, Khuri SF, El-Tamer M. Breast cancer surgery in Veterans Affairs and selected university medical centers: Results of the patient safety in surgery study. J Am Coll Surg. 2007;204:1235-1241.
43. Hanemann MS Jr, Grotting JC. Evaluation of preoperative risk factors and complication rates in cosmetic breast surgery. Ann Plast Surg. 2010;64:537-540.
44. Miller AP, Falcone RE. Breast reconstruction: Systemic factors influencing local complications. Ann Plast Surg. 1991;27:115-120.
45. Nath B, Li Y, Carroll JE, Szabo G, Tseng JF, Shah SA. Alcohol exposure as a risk factor for adverse outcomes in elective surgery. J Gastrointest Surg. 2010;14:1732-1741.
46. Khan MA, Grinberg R, Johnson S, Afthinos JN, Gibbs KE. Perioperative risk factors for 30-day mortality after bariatric surgery: Is functional status important? Surg Endosc. 2013;27: 1772-1777.
47. Borja-Cacho D, Parsons HM, Habermann EB, Rothenberger DA, Henderson WG, Al-Refaie WB. Assessment of ACS NSQIP's predictive ability for adverse events after major cancer surgery. Ann Surg Oncol. 2010;17:2274-2282.
48. Ogunleye AA, de Blacam C, Curtis MS, Colakoglu S, Tobias AM, Lee BT. An analysis of delayed breast reconstruction outcomes as recorded in the American College of Surgeons National Surgical Quality Improvement Program. J Plast Reconstr Aesthet Surg. 2012;65:289-294.
49. Costa MA, Nguyen TJ, Shahabi A, et al. Does immediate breast reconstruction affect surgical site infection? Data from the National Surgical Quality Improvement Program (NSQIP) Plast Reconstr Surg. 2011;127(Suppl 5):25.
50. Nguyen TJ, Shahabi A, Vidar EN, et al. Risk factors associated with microvascular free flap failure: Data from the ACS-National Surgical Quality Improvement Project (ACSNSQIP). Plast Reconstr Surg. 2011;127(Suppl 5):61.
51. Kapur SK, Rajamanickam V, Poore SO. A comparison of outcomes between alloplastic and autologous breast reconstruction: 2005-2010 data from the National Surgical Quality Improvement Program (NSQIP). Plast Reconstr Surg. 2012;130(Suppl 1):62.